Article

Home Testing for Sars-Cov-2 and Impact on Surveillance in New York State

2023-08-17

Abstract excerpt

Purpose: To determine the distribution of diagnosed SARS-CoV-2 infections by testing modality (at-home rapid antigen (home tests) versus laboratory-based tests in clinical settings (clinical tests)), assess factors associated with clinical testing, and estimate the true total number of diagnosed infections in New York State (NYS).<br><br>Methods: We conducted an online survey among NYS residents and analyzed data...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0157dc2f-002b-5e0e-ac0b-6c4b5a777dd3
DOI: 10.2139/ssrn.4540341

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Home Testing for Sars-Cov-2 and Impact on Surveillance in New York StateDOI 10.2139/ssrn.4540341Read

Finding a Needle in a Haystack: Design and Implementation of a Digital Site-less Clinical Study of Serial Rapid Antigen Testing to Identify Asymptomatic SARS-CoV-2 InfectionSemantic proximity Read

Use cases for COVID-19 screening and surveillance with rapid antigen-detecting tests: a systematic reviewSemantic proximity Read

Estimated SARS-CoV-2 Antibody Seroprevalence and Infection to Case Ratio Trends in 50 States and District of Columbia, United States—October 25, 2020, to February 26, 2022Semantic proximity Read

Changing epidemiology of SARS-CoV-2 positivity rates in a diverse population of children and adults during variant evolution and progressive vaccination eligibility in New York CitySemantic proximity Read

SARS-CoV-2 dynamics in New York City during March 2020–August 2023Semantic proximity Read

Comparison of Rapid Antigen Tests’ Performance between Delta (B.1.61.7; AY.X) and Omicron (B.1.1.529; BA1) Variants of SARS-CoV-2: Secondary Analysis from a Serial Home Self-Testing StudySemantic proximity Read

Diagnostic performance and clinical implications of rapid SARS-CoV-2 antigen testing in Mexico using real-world nationwide COVID-19 registry dataSemantic proximity Read

A Multi-Center Clinical Diagnostic Accuracy Study of Surestatus - an Affordable, WHO Emergency-Use-Listed, Rapid, Point-of-Care, Antigen-Detecting Diagnostic Test for SARS-CoV-2Semantic proximity Read

Association of Mass Distribution of Rapid Antigen Tests and SARS-CoV-2 Prevalence: Results from NIH-CDC funded Say Yes! Covid Test program in MichiganSemantic proximity Read

Clinical Surveillance Identifies SARS-CoV-2 Outbreaks and Emergence of Novel Variants in Real-TimeSemantic proximity Read

Then and NOW: A Prospective Population-Level Validation of the Abbott ID NOW SARS-CoV-2 Device Implemented in Multiple Settings for Testing Asymptomatic and Symptomatic IndividualsSemantic proximity Read

Wide Real-Life Data Support Reduced Sensitivity of Antigen Tests for Omicron SARS-CoV-2 Infections.Semantic proximity Read